Legacy Education Inc.
LGCY NYSE Services-Educational Services Financials FY2023βFY2026
What Legacy Education Inc. does
No business description yet.
- Legal name
- Legacy Education Inc.
- Fiscal year ends
- June 30, 2026
- Latest annual report
- 10-K Β· Sep 24, 2026
- Accession Β· CIK
- 0001493152-26-044147
0001836754
Revenue and margins
Legacy Education Inc. had $80.1M of revenue in fiscal 2026, up 24.8% on the year before.
Net income and earnings per share
From fiscal 2023 to 2026, diluted EPS grew 33.1% a year. Loss periods are shown in red.
Returns on capital
After-tax operating income as a share of the money invested in the business: debt plus equity, minus cash.
Cash flow
Free cash flow was $2.7M in fiscal 2026, 3.3% of revenue. Cash from operations minus capital spending.
Dividends, buybacks and share count
Legacy Education Inc. returned β to shareholders in fiscal 2026. The diluted share count rose 9.9%.
Balance sheet
Cash, debt and the ratios that show how comfortably Legacy Education Inc. can carry it.
| Fiscal year end | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|
| Cash and short-term investments | $9.3M | $10.4M | $20.3M | $22.7M |
| Debt incl. finance leases | $0.7M | $1.6M | $2.5M | $0.3M |
| Net debt / EBITDA | β2.2x | β1.4x | β1.7x | β1.8x |
| Debt / equity | 0.0x | 0.1x | 0.1x | 0.0x |
| Interest coverage | 37.6x | 52.6x | 88.6x | 173.2x |
| Current ratio | 2.0x | 2.3x | 2.7x | 3.7x |
| Quick ratio | 2.0x | 2.3x | 2.7x | 3.7x |
| Total assets | $27.2M | $35.2M | $69.2M | $78.5M |
| Total liabilities | $11.8M | $12.8M | $28.2M | $25.8M |
| Shareholders' equity | $15.4M | $22.4M | $41.0M | $52.8M |
| Net debt (β = net cash) | β$8.6M | β$8.8M | β$17.8M | β$22.4M |
Insider trades
Open-market purchases and sales by officers, directors and 10% owners, from Form 4 filings. 'Plan' marks trades under a pre-arranged Rule 10b5-1 plan.
Bought, 12 months
$0.0M
0 insiders
Sold, 12 months
$0.0M
0 insiders
Of sales under plans
β
$0.0M
No open-market insider trades in the last 12 months.
Piotroski F-score
Nine pass/fail tests of profitability, funding and efficiency. 8β9 is strong, 0β2 weak.
| Test | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|
| Net income is positive | β | β | β | β |
| Cash from operations is positive | β | β | β | β |
| Return on assets rose | β | β | β | β |
| Cash from operations exceeds net income | β | β | β | β |
| Debt fell relative to assets | β | β | β | β |
| Current ratio rose | β | β | β | β |
| Share count didn't rise | β | β | β | β |
| Gross margin rose | β | β | β | β |
| Revenue rose relative to assets | β | β | β | β |
| F-score | β / 3 | 5 / 8 | 5 / 8 | 6 / 8 |
| Accruals ratio | 3.3% | 11.1% | β0.4% | 6.9% |
| Altman Z'' | 4.53 | 6.24 | 5.35 | 6.90 |
4 years of figures
US$ millions unless stated. Hover a ratio's name for its definition.
| Fiscal year | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|
| Income statement | ||||
| Revenue | $35.5M | $46.0M | $64.2M | $80.1M |
| Operating income | $3.6M | $6.2M | $10.0M | $11.8M |
| Interest expense | $0.1M | $0.1M | $0.1M | $0.1M |
| Pretax income | $3.9M | $7.0M | $11.0M | $12.7M |
| Income tax | $1.2M | $1.9M | $3.5M | $3.5M |
| Net income | $2.7M | $5.1M | $7.5M | $9.1M |
| Diluted EPS | $0.28 | $0.53 | $0.59 | $0.66 |
| Diluted shares | 0.01B | 0.01B | 0.01B | 0.01B |
| Cash flow | ||||
| Cash from operations | $1.8M | $1.6M | $7.8M | $4.0M |
| Capital expenditure | $0.2M | $0.4M | $0.8M | $1.3M |
| Free cash flow | $1.6M | $1.2M | $6.9M | $2.7M |
| Depreciation and amortization | $0.2M | $0.3M | $0.4M | $0.6M |
| Stock-based compensation | β | $1.9M | $0.6M | $1.2M |
| Dividends paid | $0.9M | β | β | β |
| Dividends and buybacks | $0.9M | β | β | β |
| Balance sheet | ||||
| Cash and short-term investments | $9.3M | $10.4M | $20.3M | $22.7M |
| Total debt | $0.7M | $1.3M | $2.3M | $0.2M |
| Finance lease liabilities | β | $0.3M | $0.2M | $0.2M |
| Current assets | $17.3M | $24.6M | $37.1M | $45.8M |
| Current liabilities | $8.5M | $10.5M | $13.8M | $12.4M |
| Property and equipment, net | $0.7M | $1.0M | $2.5M | $3.2M |
| Goodwill | $1.9M | $1.9M | $6.9M | $6.8M |
| Intangible assets | $1.1M | $1.1M | $3.9M | $3.8M |
| Total assets | $27.2M | $35.2M | $69.2M | $78.5M |
| Total liabilities | $11.8M | $12.8M | $28.2M | $25.8M |
| Shareholders' equity | $15.4M | $22.4M | $41.0M | $52.8M |
| Margins | ||||
| Operating margin | 10.2% | 13.5% | 15.6% | 14.8% |
| EBITDA margin | 10.8% | 14.1% | 16.3% | 15.6% |
| Net margin | 7.5% | 11.1% | 11.7% | 11.4% |
| FCF margin | 4.4% | 2.7% | 10.8% | 3.3% |
| Returns | ||||
| Return on capital | 36.5% | 34.1% | 29.7% | 28.2% |
| Return on capital employed | 19.3% | 25.2% | 18.0% | 17.8% |
| Return on equity | 17.3% | 27.0% | 23.7% | 19.5% |
| Return on assets | 9.8% | 16.4% | 14.4% | 12.4% |
| Return on tangible equity | 21.4% | 26.3% | 24.8% | 21.7% |
| Growth | ||||
| Revenue growth | β | 29.7% | 39.5% | 24.8% |
| Net income growth | β | 91.8% | 47.3% | 21.3% |
| EPS growth | β | 89.3% | 11.3% | 11.9% |
| FCF growth | β | β22.2% | 465.2% | β61.3% |
| Share count change | β | 0.8% | 30.9% | 9.9% |
| Financial health | ||||
| Net debt / EBITDA | β2.2x | β1.4x | β1.7x | β1.8x |
| Debt / equity | 0.0x | 0.1x | 0.1x | 0.0x |
| Interest coverage | 37.6x | 52.6x | 88.6x | 173.2x |
| Current ratio | 2.0x | 2.3x | 2.7x | 3.7x |
| Quick ratio | 2.0x | 2.3x | 2.7x | 3.7x |
| Capital allocation | ||||
| Capex / revenue | 0.6% | 0.9% | 1.3% | 1.7% |
| Stock comp / revenue | β | 4.1% | 0.9% | 1.5% |
| Payouts / FCF | 58.2% | β | β | β |
| Quality scores | ||||
| Piotroski F-score | β | 5.0 | 5.0 | 6.0 |
| Altman Z'' | 4.5 | 6.2 | 5.4 | 6.9 |
| Accruals ratio | 3.3% | 11.1% | β0.4% | 6.9% |
Source: SEC EDGAR XBRL filings (CIK 0001836754). Data updated October 24, 2026. Quarterly fourth quarters are the full year minus the first nine months. For information only β not investment advice. Check the original filings before relying on any figure.